Novavax (NVAX) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 74.9%
EBITDA Margin: -91.4%
Op. Margin: -96.8%
Net Margin: -94.2%

Op. margin of -96.8% is down 139.1% YoY — costs are rising relative to revenue. Net margin at -94.2% and gross margin of 74.9% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit